MannKind Corporation Says No Afresa Partnership In 2009

October 7, 2009 |

1 min read

Twitter
LinkedIn
Facebook
Email
Print

Reuters - MannKind Corp (MNKD.O) said it would be unable to conclude a partnership deal for its inhaled insulin product, Afresa, by year-end as it plans to wait for the U.S. health regulator's response on its new drug application for the product.

Twitter
LinkedIn
Facebook
Email
Print

Alliances